Please login to the form below

Not currently logged in
Email:
Password:

J&J Ortho-McNeil division recalls Topamax

Johnson & Johnson's (J&J) Ortho-McNeil Neurologics Division has recalled two batches of its anti-seizure drug Topamax (topiramate) due to reports of an odour

Johnson & Johnson's (J&J) Ortho-McNeil Neurologics Division has recalled two batches, amounting to around 57,000 bottles, of its anti-seizure drug Topamax (topiramate) due to reports of an odour thought to be caused by trace amounts of TBA (2,4,6 tribromoanisole). TBA is a byproduct of a chemical preservative sometimes applied to wood often used in the construction of pallets on which products are transported and stored. 

The company said that although all bottles in the affected batches have been recalled, it believes fewer than 6,000 bottles remain in the marketplace. J&J has said that it does not anticipate a product shortage as a result of the recall.

J&J has initiated the recall voluntarily, in cooperation with the US Food and Drug Administration (FDA). The company will be carrying out investigations with its suppliers to verify that pallets treated with chemically-treated wood are not being used for the shipment of products.

Earlier this week, J&J appointed Denice Torres to lead its McNeil Consumer Healthcare division, which has recently has faced dozens of high-profile product recalls including Children's Tylenol, Motrin, Zyrtec and Benadryl.

14th April 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics